Which factors may determine the necessary and feasible type of effectiveness evidence? A mixed methods approach to develop an instrument to help coverage decision-makers

methodsBMJ Open

Nov 18

Written by Matthijs Versteegh

Matthijs Versteegh

Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma

Introducing the composite time trade-off: a test of feasibility and face validity